Old versus new: weighing the evidence between the firstand second-generation antipsychotics

被引:22
作者
Davis, JM [1 ]
Chen, N [1 ]
机构
[1] Univ Illinois, Univ Maryland Psychiat Res Ctr, Dept Psychiat, Chicago, IL 60680 USA
关键词
antipsychotics; meta-analysis; efficacy; dose;
D O I
10.1016/j.eurpsy.2004.11.002
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In our opinion the best guide to prescribing antipsychotics is the clinician's experience with his patients and in particular the patient being treated. If treatment works. stick with it. We feel it is also important for the clinician to consider the evidence front well-controlled double-blind random-assignment studies because in "evidence-based medicine," biases both known and unknown are controlled by blinding, and randomization. The purpose of this paper is to summarize and discuss the evidence on efficacy. Choice of antipsychotic. in our opinion. is probably the most important decision that the clinician makes for the psychotic patient. This involves the choice of drug. its dose. balancing efficacy, side-effects and cost. (C) 2004 Published by Elsevier SAS.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 23 条
[11]   Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects [J].
Halbreich, U ;
Kinon, BJ ;
Gilmore, JA ;
Kahn, LS .
PSYCHONEUROENDOCRINOLOGY, 2003, 28 :53-67
[12]  
Hamner Mark, 2002, Ann Clin Psychiatry, V14, P163, DOI 10.1023/A:1021138603935
[13]  
KENNEDY E, 2002, COCHRANE REV CDROM
[14]   Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials [J].
Leucht, S ;
Pitschel-Walz, G ;
Abraham, D ;
Kissling, W .
SCHIZOPHRENIA RESEARCH, 1999, 35 (01) :51-68
[15]   Amisulpride, an unusual "atypical" antipsychotic: A meta-analysis of randomized controlled trials [J].
Leucht, S ;
Pitschel-Walz, G ;
Engel, RR ;
Kissling, W .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (02) :180-190
[16]   Amisulpride is an "atypical" antipsychotic associated with low weight gain [J].
Leucht, S ;
Wagenpfeil, S ;
Hamann, J ;
Kissling, W .
PSYCHOPHARMACOLOGY, 2004, 173 (1-2) :112-115
[17]   New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-manalysis [J].
Leucht, S ;
Wahlbeck, K ;
Hamann, J ;
Kissling, W .
LANCET, 2003, 361 (9369) :1581-1589
[18]  
MAY PRA, 1976, ARCH GEN PSYCHIAT, V33, P481
[19]  
SRISURAPANONT M, 2002, COCHRANE REV CDROM
[20]  
WAHLBECK K, 2002, COCHRANE REV CDROM